Billionaires Holding MDCO

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 64.5M
    Shares Outstanding

  • 2.45B
    Market Cap

News & Insights

ABOUT

MDCO

The Medicines Company provides medical solutions for patients in acute and intensive care hospitals worldwide. The company markets Angiomax, an intravenous direct thrombin inhibitor used as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous trans...

Introducing The New Elon Musk Strategy

NEWS

iBillionaire Joins Forces With IBM Watson

READ MORE